Episode 92: Doxorubicin: The Infamous Red Devil
Feb 28, 2020•20 min•Season 1Ep. 92
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
ONS member Christine Rimkus, RN, MSN, AOCN®, clinical nurse specialist for the Siteman Cancer Center at Washington University in St. Louis, MO, and member of the St. Louis ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss doxorubicin—otherwise known as the red devil—chemotherapy administration, what nurses need to know about vesicants in practice, and how to support and advocate for patients receiving doxorubicin treatment.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons: By Attribution 3.0
Episode Notes
Check out these resources from today's episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil
- The Case of the Vexing Vesicant
- Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers
- Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
- Understanding and Managing Oncologic Emergencies: A Resource for Nurses (Third Edition)
For the best experience, listen in Metacast app for iOS or Android